Skip to content

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Peripheral Vascular Diseases

The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* Patients 18 years and older
* Written informed consent (patient data release-form)
* Use of any commercially available Boston Scientific drug-eluting device marketed for treatment of lesions in the peripheral vasculature and specified in the Registry Enrollment Guide

Exclusion Criteria:

* Life expectancy of \<1 year

Study Location

Peter Lougheed Centre-Hospital
Peter Lougheed Centre-Hospital
Calgary, Alberta
Canada

Contact Study Team

CHUS - Hotel Dieu
CHUS - Hotel Dieu
Sherbrooke, Quebec
Canada

Contact Study Team

Study Sponsored By
Boston Scientific Corporation
Participants Required
More Information
Study ID: NCT04674969